Загрузка...
Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
BACKGROUND: BRAF mutation has been recognized as an important biomarker of colorectal cancer (CRC) for targeted therapy and prognosis prediction. However, sequencing for every CRC case is not cost-effective. An antibody specific for BRAF V600E mutant protein has been introduced, and we thus examined...
Сохранить в:
| Опубликовано в: : | J Pathol Transl Med |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5964290/ https://ncbi.nlm.nih.gov/pubmed/29590746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2018.03.28 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|